Impact Factor
3.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.56
208 total citations
h5-index
20
h5 depth signal
Cited share
77.4%
72 of 93
Total citations
208
Citation footprint
Metric signal
3.08
External metric anchor
Self-citation
0.5%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
182
Poland
152
Saudi Arabia
25
Pakistan
21
Turkey
21
Citing Fields of Research
Bacteriology
239
Antibiotic & Antibacterial Agents
137
Industrial Microbiology
75
Inflammatory Bowel Diseases & Infections
60
Plant Pathology
50
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
881
Articles tracked across the journal lifetime
Indexed publication set
93
72 cited publications
Last 12 months
30
7.5 publications/month
Open access share
100.0%
30 OA publications in the last year
Leading citing country
China
182 citing publications
Leading citing field
Bacteriology
239 citing publications
Latest tracked publication
29 June 2026
10 recent records available
Coverage & Indexing History
v53n1, 2004-
v53n1, 2004-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Bacteriology
Inflammatory Bowel Diseases & Infections
Virology
Fungal Pathogenesis
Issuing & Sponsoring Bodies
Contributor
Polskie Towarzystwo Mikrobiologów
Broad Categories
Microbiology
Antibiotic & Antibacterial Agents
Inflammatory Bowel Diseases & Infections
Bacteriology
Plant Pathology
Digestive Disorders
Virology
MeSH Descriptors
Microbiology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.33073/pjm-2026-020
Open DOI
Rapid Detection of Pathogens and Resistance Genes in Positive Blood Cultures Using BioFire ® FilmArray BCID2
Bloodstream infections cause significant morbidity and mortality, and rapid identification of the causative microorganisms, along with their antimicrobial resistance profiles, is crucial for appropriate treatment. Molecular diagnostic sy...
02
DOI 10.33073/pjm-2026-017
Open DOI
Longitudinal Changes in Selected Gut Microorganisms During Gluten-Free Diet in Pediatric Coeliac Disease
Alterations in gut microbiota have been reported in coeliac disease (CeD). However, longitudinal evidence distinguishing disease-related effects from diet-driven changes after gluten-free diet initiation remains scarce, particularly in p...
03
DOI 10.33073/pjm-2026-023
Open DOI
Machine Learning–Driven Prediction of Early Enteral Nutrition Intolerance in ICU Patients Using Intra-Abdominal Pressure and Selected Gut Microbial Taxa
To develop and validate a machine learning model integrating intra-abdominal pressure (IAP) and gut microbial characteristics for early identification of enteral nutrition intolerance (EENI) in critically ill ICU patients. This cohort st...
04
DOI 10.33073/pjm-2026-022
Open DOI
Characteristics of Placental Bacterial DNA Communities in Pregnant Women with Gestational Diabetes Mellitus and Association with Early Neonatal Gut Microbiota and Short-Term Perinatal Outcomes
Gestational diabetes mellitus (GDM) affects maternal metabolism and may be associated with altered placental bacterial DNA community profiles and early neonatal gut microbiota. This prospective cohort study assesses GDM’s impact on the p...
05
DOI 10.33073/pjm-2026-015
Open DOI
A Pilot Longitudinal 16S rRNA Gene Sequencing Study Exploring the Relationship Between Gut Microbiota and Body Composition in Healthy Adults
The gut microbiome is linked to body composition, yet most studies involve probiotic or dietary interventions. This study explored relationships between changes in body composition and the fecal microbiota under natural lifestyle conditi...
06
DOI 10.33073/pjm-2026-019
Open DOI
In Vitro Antibacterial Activity of Sulbactam-Durlobactam and Eravacycline Against Carbapenem-Resistant Acinetobacter baumannii in China and Analysis of Sulbactam-Durlobactam Resistance Mechanisms
The management of carbapenem-resistant Acinetobacter baumannii (CRAB) infections remains a formidable clinical challenge. This study evaluated the in vitro antimicrobial activities of sulbactam-durlobactam (SUL-DUR) and eravacycline (ERV...
07
DOI 10.33073/pjm-2026-012
Open DOI
Microbial Signatures in Head and Neck versus Gastrointestinal Tumors: Identification and Prognostic Modeling
This study identified key intra-tumor microbial signatures distinguishing head and neck cancers from gastrointestinal cancers and explored their diagnostic and prognostic potential. Intra-tumor microbial data of five cancer types were ob...
08
DOI 10.33073/pjm-2026-016
Open DOI
Distinct Gut Microbiome and Metabolome Profiles Associate with Differential Responses to Immunotherapy in Colorectal Cancer
The composition of the intestinal microbiome has been identified as a key factor influencing the efficacy of immune checkpoint inhibitors. This study aimed to systematically evaluate the potential associations among gut microbiota, metab...
09
DOI 10.33073/pjm-2026-001
Open DOI
Characteristics of Gut Microbiota in Patients with Severe Pneumonia and its Potential Clinical Relevance
Gut microbiota is associated with a variety of diseases, but its relationship with severe pneumonia remains to be explored. This study primarily analyzed the intestinal microbiota of patients with severe pneumonia and examined its associ...
10
DOI 10.33073/pjm-2026-013
Open DOI
Multidrug-Resistant Salmonella and Shigella : Epidemiology, Resistance Mechanisms, and Emerging Therapeutic Strategies
The review article is a critical examination of the growing global problem of multidrug-resistant (MDR) Salmonella and Shigella , focusing on their epidemiology, molecular resistance mechanisms, and clinical effects. It compiles current ...
Bibliographical & Catalog Notes
Also issued online.